ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,920Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 656

$3.95M Total Retail Price of All Prescriptions

Rank: 1 out of 656

1,630 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,630 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

1% of this provider’s 1,630 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 11,659 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$199 was the average price of a prescription from this provider, compared to $147 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NAMENDA 1,880 1,771 1 22
OLANZAPINE 1,558 1,114 10 2 12
ZOLPIDEM TARTRATE 1,064 496 3 3
EXELON 964 934 10 4 36
DONEPEZIL HCL 964 841 4 33
CITALOPRAM HBR 636 501 6 9
ABILIFY 632 322 7 6
ESCITALOPRAM OXALATE 625 427 8 18
QUETIAPINE FUMARATE 619 412 9 5
MIRTAZAPINE 568 420 10 13
FLUOXETINE HCL 536 174 11 11
CYMBALTA 508 282 12 7
PRISTIQ ER 501 216 10 13 30
RISPERIDONE 464 214 14 2
SERTRALINE HCL 344 205 15 8
LUNESTA 322 122 10 16 51
VENLAFAXINE HCL ER 289 172 17 15
SYMBYAX 287 167 10 18 86
ZYPREXA 282 210 10 19 52
HYDROXYZINE PAMOATE 270 28 R 20 32
SEROQUEL 262 176 21 20
SEROQUEL XR 251 88 22 21
OLANZAPINE ODT 251 150 10 22 64
TRAZODONE HCL 247 94 24 1
BENZTROPINE MESYLATE 230 66 R 25 4
LEXAPRO 226 142 26 47
LAMOTRIGINE 214 29 27 14
LITHIUM CARBONATE 211 53 28 16
DIVALPROEX SODIUM ER 202 75 29 10
PAROXETINE HCL 179 100 30 23
ZOLPIDEM TARTRATE ER 153 63 10 31 76
ARICEPT 144 132 32 80
SAPHRIS 142 38 33 60
DIVALPROEX SODIUM 141 51 34 24
INVEGA 133 30 35 38
OXCARBAZEPINE 129 18 36 28
BUPROPION XL 118 13 37 17
TOPIRAMATE 110 0 38 34
LEVOTHYROXINE SODIUM 93 50 39 50
PANTOPRAZOLE SODIUM 76 36 40 92
CLOZAPINE 71 0 41 31
NEXIUM 69 28 42 134
CRESTOR 67 44 43 116
LISINOPRIL 65 21 44 61
OLANZAPINE-FLUOXETINE HCL 60 30 10 45 142
AMLODIPINE BESYLATE 58 32 46 71
LYRICA 57 27 47 105
ZIPRASIDONE HCL 56 0 48 27
FAZACLO 54 11 49 68
GALANTAMINE HBR 54 45 49 125
RIVASTIGMINE 53 37 51 103
CARBAMAZEPINE 52 12 52 35
LATUDA 50 0 53 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.